PUBLISHER: Grand View Research | PRODUCT CODE: 1133327
PUBLISHER: Grand View Research | PRODUCT CODE: 1133327
The global cellular health screening market size is expected to reach USD 5.62 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.2% from 2022 to 2030. The growing geriatric population and consequent growth in the requirement for cellular health screening are majorly driving the market. In addition, the rising adoption of the direct-to-consumer approach, the growing importance of healthy life expectancy (HALE), increasing telomere performance programs for leading a healthy life, and rising government focus on preventive healthcare are expected to drive the market.
An increasing number of individuals undergoing cellular health screening testing, such as telomere tests, to learn about the biomarkers of cell aging is also anticipated to supplement the market growth. It has been demonstrated that tests that provide information on telomere length and activity can also provide information on lifestyle and stress factors. Numerous studies have demonstrated that both acute stress and chronic stress accelerate cell aging. Thus, these tests play an important role in understanding one's health.
Additionally, researchers can gain insights into cellular qualities by studying how physical exercise, sleep, mental health issues, alcohol use, and smoking habits alter cellular aging in various ways. The utilization of telomere tests offers insights into metabolic and genetic illnesses, enabling clinicians to make an early diagnosis and quickly and individually tailor a patient's treatment regimen. Consequently, growing interest in cellular screening and expanding research have increased kit and test demand, facilitating market growth in recent years.
The necessity for cellular screening research has grown as a result of its many applications in preventive medicine and the capacity to comprehend relationships between telomere length and aging. Bio-cell-based screenings are frequently advised throughout time, allowing patients to compare results and comprehend what modifications need to be made. Monitoring these alterations in cellular health between screenings enables quick adjustments to be made in terms of health protocols and a general improvement in illness management.
Furthermore, disorders related to aging are linked to the buildup of old, dysfunctional cells. As shown in several animal trials, research has recently established that these can be reversed by employing a variety of cellular health procedures. Consequently, it is anticipated that ongoing research and development activities in the disciplines of protein expression, proteomics, and genomics are anticipated to further boost the demand for cellular health screening products in the near future.